Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00885521 |
Recruitment Status :
Completed
First Posted : April 22, 2009
Last Update Posted : March 11, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of this project is to examine the short and long term effects of an 8 week, twice weekly, outpatient exercise training program for people with bronchiectasis. Participants will be randomly allocated to undergo a supervised exercise training program at The Alfred, Austin Hospital or Sir Charles Gairdner Hospital.
The hypotheses of this study are:
- Patients with bronchiectasis who complete an exercise program will have a higher exercise capacity and better quality of life and these improvements will be sustained for up to 12 months after completion
- Exercise training will significantly reduce the incidence of pulmonary exacerbations, use of antibiotics and rate of hospitalisation
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bronchiectasis | Other: Exercise | Phase 1 |
Bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis) is a chronic respiratory condition characterised by permanent dilatation of the airways arising from bronchial inflammation and infection. Predominant symptoms include daily productive cough, dyspnoea and generalised fatigue. This profile is associated with diminished health-related quality of life (HRQOL) and reduced exercise tolerance.
Available medical treatments for bronchiectasis include antibiotic and inhalation therapy. To date, there is no evidence that these treatments can reduce the exacerbation rate or modify the rate of disease progression. While international guidelines for pulmonary rehabilitation recommend the inclusion of patients with bronchiectasis, there is a deficiency in evidence supporting exercise training in this population. It is proposed that a standard exercise training program conducted according to Australian guidelines for pulmonary rehabilitation will improve both exercise capacity, quality of life and reduce the number of acute infections in both the short and long term in people with bronchiectasis.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 39 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Exercise Training in Patients With Non-CF Bronchiectasis - a Multi-centre Randomized Controlled Trial |
Study Start Date : | February 2009 |
Actual Primary Completion Date : | February 2013 |
Actual Study Completion Date : | February 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Exercise
8 week, twice weekly exercise program with both endurance and upper and lower limb strength training
|
Other: Exercise
8 week, twice weekly exercise program with endurance and upper and lower limb strength training |
No Intervention: 2
No exercise, twice weekly phone calls
|
- Incremental Shuttle Walk Test Chronic Respiratory Disease questionnaire [ Time Frame: July 2011 ]
- 6-Minute Walk Test [ Time Frame: July 2011 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of bronchiectasis (HRCT)
- Stable medical status for last 4 weeks
- History of 2 exacerbations in the last 2 years
- Dysnpoea on exertion (Modified Medical Research Council score >1)
Exclusion Criteria:
- Concurrent diagnosis of COPD (physician diagnosis and history of 10 pack year smoking)
- Concurrent diagnosis of asthma (history of atopic disease and evidence of bronchodilator reversibility of 12% or 200ml in FEV1 or FVC)
- Concurrent diagnosis of Interstitial lung disease
- Concurrent diagnosis of Cystic Fibrosis
- Medical condition which could place patient at risk during exercise training (angina, neurological or orthopaedic condition)
- Prior completion of pulmonary rehabilitation within the last 12 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00885521
Australia, Victoria | |
The Alfred | |
Melbourne, Victoria, Australia, 3004 | |
Austin Health | |
Melbourne, Victoria, Australia | |
Australia, Western Australia | |
Sir Charles Gairdner Hospital | |
Perth, Western Australia, Australia |
Principal Investigator: | Annemarie L Lee, PhD | Bayside Health |
Responsible Party: | Bayside Health |
ClinicalTrials.gov Identifier: | NCT00885521 |
Other Study ID Numbers: |
348/08 |
First Posted: | April 22, 2009 Key Record Dates |
Last Update Posted: | March 11, 2014 |
Last Verified: | March 2014 |
Bronchiectasis Bronchial Diseases Respiratory Tract Diseases |